ReviewRSC advances2026
A review of commercial and laboratory-based microfluidic devices based on glass and/or silicon substrates.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integrating Low-Voltage Microfluidics With On-Chip Electrospray Ionization for Miniaturized Protein Analysis.Small methods · 2026Review
- Capillary-Driven Microfluidic Electrical Screening of Influenza H3N2-Infected A549 Cells Using AgNP-Decorated Laser-Patterned Villous Microstructures.Biosensors · 2026Article
- Microfluidics in Intelligent Fresh Produce Preservation and Detection: From Precision Sensing to Active Delivery Systems.Comprehensive reviews in food science and food safety · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microfluidic devices are increasingly being sought after as powerful alternatives to traditional macroscopic benchtop biochemical analysis systems due to their lower cost, faster analysis times, and reduced reagent consumption. Advances in additive manufacturing and semiconductor fabrication have simplified device realization, enabling their integration into a wide range of biochemical applications. Microfluidic devices were initially fabricated using glass and silicon as substrate materials. However, as the demand for more complex structures has increased, new materials have been introduced. Among these are soft and thermoplastic polymers, which are well suited to techniques such as soft molding, injection molding, and hot embossing. Despite these developments, surface-treated glass and silicon are preferred for high-grade analyses due to their superior chemical, biological, thermal, and physical properties. In this review, we highlight recent progress in commercially and semi-commercially available microfluidic devices based on glass and silicon substrates. We summarize key fabrication methods and their applications and examine how these platforms are advancing toward integrated readout, actuation, and sensing capabilities for a complete lab-on-a-chip system.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.